Boston, MA · Founded 2018 · Privately Held (backing)
Provider of clinical research and development services intended to treat systemic and life-threatening fungal infections. Elion Therapeutics is based in Boston, MA and was founded in 2018. Its last reported valuation was $163 million in Aug 2025. It has raised $111 million.
Last reported valuation
$163.0M
Oct 2026
Priced at
—
Total raised
$111.0M
Last round
—
Cap table — not yet on record
Elion Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Elion Therapeutics with a free account
·Watch Elion Therapeutics: the Monday email on marks, rounds and moves
